Lilly investors got the jitters, saw better opportunities elsewhere, or decided to hold onto their chips. In the third ...

Indiana business owners and investors had a solid 2024. Jane King, a NASDAQ Analyst, says 2024 was a banner year for the ...

Novo Nordisk and Eli Lilly are currently a duopoly in the obesity market, which reached a value of $24 billion last year ...

"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in adults with obesity." ...

“It's pretty obvious that there's a big hope for him and his ability to turn that company around,” says executive coach Alisa Cohn, who explains that top pay packages are set by a company’s ...